Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

US Innovative Healthcare Ishares Evolved ETF (IEIH)

US Innovative Healthcare Ishares Evolved ETF (IEIH)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fund Basics

See More
  • Fund Family BlackRock iShares
  • Assets Under Management 4,844,000
  • Market Capitalization, $K 4,844
  • Shares Outstanding, K 200
  • 60-Month Beta 1.00
  • Price/Earnings ttm 24.87
  • Annual Dividend & Yield 0.88 (3.63%)
  • Most Recent Dividend 0.104 on 03/25/20
  • Management Fee 0.18%
  • Sectors:

Price Performance

See More
Period Period Low Period High Performance
1-Month
22.07 +14.70%
on 03/23/20
28.18 -10.16%
on 03/04/20
-0.96 (-3.64%)
since 02/28/20
3-Month
22.07 +14.70%
on 03/23/20
28.94 -12.52%
on 02/11/20
-2.79 (-9.94%)
since 12/27/19
52-Week
22.07 +14.70%
on 03/23/20
28.94 -12.52%
on 02/11/20
-0.68 (-2.62%)
since 03/29/19

Most Recent Stories

More News
Wanna Be a Value Investor? Follow Buffett & Play 2 ETF Areas

Warren Buffett took positions in Biogen and Kroger. Investors who want to follow Buffett's picking of these two value stocks can also play these ETFs as well.

BIIB : 316.13 (+6.53%)
AMZN : 1,963.95 (+3.36%)
WMT : 115.19 (+5.12%)
KR : 29.65 (+1.79%)
IBB : 108.84 (+3.94%)
BBH : 128.68 (+3.71%)
FTXD : 18.42 (+2.36%)
FXG : 40.43 (+3.06%)
IEIH : 25.31 (+4.41%)
JNJ Beats, Ups View: Healthcare ETFs to Buy

Johnson & Johnson continued its long streak of earnings beat and outpaced revenue estimates. It also raised its guidance for the full year.

JNJ : 133.01 (+8.00%)
XLV : 88.97 (+4.68%)
IYH : 188.37 (+4.65%)
IHE : 135.64 (+5.11%)
VHT : 166.77 (+4.30%)
IEIH : 25.31 (+4.41%)
Amgen to Buy Celgene's Otezla: 5 ETF Drugs

Amgen agreed to buy psoriasis and psoriatic arthritis drug Otezla from Celgene for $13.4 billion in cash.

NVS : 81.90 (+3.30%)
BMY : 54.39 (+3.03%)
BBH : 128.68 (+3.71%)
PJP : 54.84 (+5.60%)
IBB : 108.84 (+3.94%)
PBE : 46.72 (+3.75%)
CELG : 108.24 (+0.10%)
AMGN : 208.48 (+5.15%)
IEIH : 25.31 (+4.41%)
Healthcare ETFs in Focus on JNJ's Q2 Earnings Beat

Johnson & Johnson beat the second-quarter earnings and revenue estimates but warned on competition from generics and biosimilars that could impact its third-quarter results.

JNJ : 133.01 (+8.00%)
IHE : 135.64 (+5.11%)
XLV : 88.97 (+4.68%)
IYH : 188.37 (+4.65%)
VHT : 166.77 (+4.30%)
IEIH : 25.31 (+4.41%)
JNJ Beats, Ups Sales Growth View: Healthcare ETFs in Focus

Johnson & Johnson continued its long streak of earnings beat and also outpaced revenue estimates. Though it raised the guidance for full-year sales growth, it tightened the earnings per share forecast....

XLV : 88.97 (+4.68%)
VHT : 166.77 (+4.30%)
IHE : 135.64 (+5.11%)
IYH : 188.37 (+4.65%)
IEIH : 25.31 (+4.41%)
JNJ Beats, Ups Sales Growth View: Healthcare ETFs in Focus

Johnson & Johnson continued its long streak of earnings beat and also outpaced revenue estimates. Though it raised the guidance for full-year sales growth, it tightened the earnings per share forecast....

XLV : 88.97 (+4.68%)
VHT : 166.77 (+4.30%)
IHE : 135.64 (+5.11%)
IYH : 188.37 (+4.65%)
IEIH : 25.31 (+4.41%)
Trump Proposes 2020 Budget: ETFs to Top & Flop

Here are the key takeaways from the proposed 2020 budget and their expected impact on ETFs.

QCLN : 19.94 (-0.20%)
ITA : 147.57 (-0.98%)
BTEC : 31.75 (+2.28%)
CNCR : 20.01 (+3.43%)
XLP : 55.60 (+3.91%)
GNRX : 22.42 (-0.06%)
BBC : 29.64 (+2.38%)
EWW : 27.68 (-0.86%)
PBW : 26.84 (+0.41%)
XAR : 77.51 (-0.32%)
MOO : 51.39 (+3.97%)
CARZ : 24.31 (-0.37%)
PPA : 50.96 (+0.14%)
IEIH : 25.31 (+4.41%)
Trump Proposes 2020 Budget: ETFs to Top & Flop

Here are the key takeaways from the proposed 2020 budget and their expected impact on ETFs.

QCLN : 19.94 (-0.20%)
ITA : 147.57 (-0.98%)
BTEC : 31.75 (+2.28%)
CNCR : 20.01 (+3.43%)
XLP : 55.60 (+3.91%)
GNRX : 22.42 (-0.06%)
BBC : 29.64 (+2.38%)
EWW : 27.68 (-0.86%)
PBW : 26.84 (+0.41%)
XAR : 77.51 (-0.32%)
MOO : 51.39 (+3.97%)
CARZ : 24.31 (-0.37%)
PPA : 50.96 (+0.14%)
IEIH : 25.31 (+4.41%)
JNJ Beats, Offers Bleak Outlook: Health Care ETFs in Focus

Johnson & Johnson expects its sales growth to slow down this year due to pricing pressures and generic-drug competition for its pharmaceutical division. This has put healthcare ETFs in focus.

JNJ : 133.01 (+8.00%)
XLV : 88.97 (+4.68%)
IHE : 135.64 (+5.11%)
VHT : 166.77 (+4.30%)
IYH : 188.37 (+4.65%)
IEIH : 25.31 (+4.41%)
JNJ Beats, Offers Bleak Outlook: Health Care ETFs in Focus

Johnson & Johnson expects its sales growth to slow down this year due to pricing pressures and generic-drug competition for its pharmaceutical division. This has put healthcare ETFs in focus.

JNJ : 133.01 (+8.00%)
XLV : 88.97 (+4.68%)
IHE : 135.64 (+5.11%)
VHT : 166.77 (+4.30%)
IYH : 188.37 (+4.65%)
IEIH : 25.31 (+4.41%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 40% Sell with a Weakening short term outlook on maintaining the current direction.

See More Share

Trade IEIH with:

Fund Summary

The iShares Evolved U.S. Innovative Healthcare ETF seeks to provide access to U.S. companies with innovative healthcare exposure, as classified using a proprietary classification system.

See More

Top 10 Holdings

Key Turning Points

2nd Resistance Point 25.70
1st Resistance Point 25.51
Last Price 25.31
1st Support Level 24.92
2nd Support Level 24.54

See More

52-Week High 28.94
Fibonacci 61.8% 26.31
Fibonacci 50% 25.50
Last Price 25.31
Fibonacci 38.2% 24.69
52-Week Low 22.07

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar